Please wait while we open this resource.
K
Clinical reviews
ACROMEGALY: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT
Health & Science University, Portland, OR, USA
PDF202223 pages1.2 MB
Acromegaly is primarily caused by growth hormone-secreting pituitary adenomas, which are typically benign but can lead to significant morbidity. The review discusses the epidemiology, pathogenesis, complications, and treatment options available for acromegaly. Key therapeutic goals include normalizing IGF-1 and growth hormone levels, tumor shrinkage, and managing associated comorbidities. The document highlights the need for individualized treatment approaches to improve patient quality of life.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology